Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)

Neurobiology of Disease

Volumn 82, Issue , 2015, Pages 445-454

  Lourenco, Guinevere F ^a,b   Janitz, Michael ^c   Huang, Yue ^a,b   Halliday, Glenda M ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Frontotemporal lobar degeneration; FUS TLS; Long noncoding RNA; Neurodegeneration; TDP 43

Indexed keywords

CELL PROTEIN; CYCLIN D1; FUSED IN SARCOMA PROTEIN; HISTONE ACETYLTRANSFERASE; LIVER SPECIFIC TRIGLYCERIDE REGULATOR; LONG UNTRANSLATED RNA; NUCLEAR ENRICHED ABUNDANT TRANSCRIPT 1; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; PROTEIN TDP-43; RNA BINDING PROTEIN;

BINDING SITE; CELL INCLUSION; DISEASE ASSOCIATION; FRONTOTEMPORAL DEMENTIA; GADD7 GENE; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HIGH THROUGHPUT SCREENING; HUMAN; NERVE CELL NECROSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN RNA BINDING; PROTEIN TARGETING; PROTEINOSIS; REVIEW; TDP 43 PROTEINOPATHY; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; ANIMAL; GENETICS; METABOLISM;

ANIMALS; DNA-BINDING PROTEINS; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; RNA, LONG NONCODING; RNA-BINDING PROTEIN FUS;

EID: 84939604231     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.07.011     Document Type: Review

References (116)

1. Abeliovich A. Neurological disorders: quality-control pathway unlocked. Nature 2014, 510:44-45.
2. Amador-Ortiz C., et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann. Neurol. 2007, 61:435-445.
3. Annilo T., et al. Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression. BMC Mol. Biol. 2009, 10:81.
4. Arisi I., et al. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. J. Alzheimers Dis. 2011, 24:721-738.
5. Ash P.E., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 2013, 77:639-646.
6. Baloh R.H. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?. Curr. Opin. Neurol. 2012, 25:701-707.
7. Bird T., et al. Epidemiology and genetics of frontotemporal dementia/Pick's disease. Ann. Neurol. 2003, 54(Suppl. 5):S29-S31.
8. Broe M., et al. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 2003, 60:1005-1011.
9. Cairns N.J., et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007, 114:5-22.
10. Chare L., et al. New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications. J. Neurol. Neurosurg. Psychiatry 2014, 85:865-870.
11. Che M.X., et al. TDP-35 sequesters TDP-43 into cytoplasmic inclusions through binding with RNA. FEBS Lett. 2015, 589:1920-1928.
12. Chen L.L., Carmichael G.G. Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol. Cell 2009, 35:467-478.
13. Chiba M., et al. Existence of Pink1 antisense RNAs in mouse and their localization. Cytogenet. Genome Res. 2009, 126:259-270.
14. Consortium E.P. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004, 306:636-640.
15. Cooper-Knock J., et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. Brain 2014, 137:2040-2051.
16. de Aguiar Vallim T.Q., et al. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013, 17:657-669.
17. DeJesus-Hernandez M., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
18. Derrien T., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22:1775-1789.
19. Diehl J., Kurz A. Frontotemporal dementia: patient characteristics, cognition, and behaviour. Int. J. Geriatr. Psychiatry 2002, 17:914-918.
20. Dobson-Stone C., et al. C9ORF72 repeat expansion in Australian and Spanish frontotemporal dementia patients. PLoS One 2013, 8:e56899.
21. Doi H., et al. RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells. J. Biol. Chem. 2008, 283:6489-6500.
22. Doi H., et al. The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci. Res. 2010, 66:131-133.
23. Dols-Icardo O., et al. Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Hum. Mol. Genet. 2014, 23:749-754.
24. Donnelly C.J., et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 2013, 80:415-428.
25. Ebralidze A.K., et al. PU.1 expression is modulated by the balance of functional sense and antisense RNAs regulated by a shared cis-regulatory element. Genes Dev. 2008, 22:2085-2092.
26. Edwards C.A., Ferguson-Smith A.C. Mechanisms regulating imprinted genes in clusters. Curr. Opin. Cell Biol. 2007, 19:281-289.
27. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
28. Faghihi M.A., et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 2008, 14:723-730.
29. Feldman H., et al. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology 2003, 22:265-274.
30. Fornace A.J., et al. DNA damage-inducible transcripts in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:8800-8804.
31. Geser F., et al. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J. Neurol. 2009, 256:1205-1214.
32. Gong C., Maquat L.E. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements. Nature 2011, 470:284-288.
33. Gonzalez I., et al. A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature. Nat. Struct. Mol. Biol. 2015, 22:370-376.
34. Gorno-Tempini M.L., et al. Classification of primary progressive aphasia and its variants. Neurology 2011, 76:1006-1014.
35. Gu R., et al. Gene regulation by sense-antisense overlap of polyadenylation signals. RNA 2009, 15:1154-1163.
36. Guru S.C., et al. A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res. 1997, 7:725-735.
37. Gutschner T., Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012, 9:703-719.
38. Haerty W., Ponting C.P. Unexpected selection to retain high GC content and splicing enhancers within exons of multiexonic lncRNA loci. RNA 2015, 21:333-346.
39. Helzner E.P., et al. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology 2008, 71:1489-1495.
40. Hodges J.R., et al. Survival in frontotemporal dementia. Neurology 2003, 61:349-354.
41. Hoell J.I., et al. RNA targets of wild-type and mutant FET family proteins. Nat. Struct. Mol. Biol. 2011, 18:1428-1431.
42. Hollander M.C., et al. A novel DNA damage-inducible transcript, gadd7, inhibits cell growth, but lacks a protein product. Nucleic Acids Res. 1996, 24:1589-1593.
43. Hube F., et al. Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiation. Nucleic Acids Res. 2011, 39:513-525.
44. Hung T., et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat. Genet. 2011, 43:621-629.
45. Hutchinson J.N., et al. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 2007, 8:39.
46. Impey S., et al. Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 2004, 119:1041-1054.
47. Ishihara T., et al. Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013, 22:4136-4147.
48. Jackel S., et al. Nuclear import factor transportin and arginine methyltransferase 1 modify FUS neurotoxicity in Drosophila. Neurobiol. Dis. 2015, 74:76-88.
49. Kaikkonen M.U., et al. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc. Res. 2011, 90:430-440.
50. Kersaitis C., et al. Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol. 2004, 108:515-523.
51. King A., et al. Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease. Neuropathology 2010, 30:408-419.
52. Kino T., et al. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal. 2010, 3:ra8.
53. Knopman D.S., Roberts R.O. Estimating the number of persons with frontotemporal lobar degeneration in the US population. J. Mol. Neurosci. 2011, 45:330-335.
54. Kril J.J., Halliday G.M. Pathological staging of frontotemporal lobar degeneration. J. Mol. Neurosci. 2011, 45:379-383.
55. Kung J.T., et al. Long noncoding RNAs: past, present, and future. Genetics 2013, 193:651-669.
56. Kusters B., et al. TDP-43 accumulation is common in myopathies with rimmed vacuoles. Acta Neuropathol. 2009, 117:209-211.
57. Lagier-Tourenne C., et al. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010, 19:R46-R64.
58. Lagier-Tourenne C., et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012, 15:1488-1497.
59. Law J.A., Jacobsen S.E. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet. 2010, 11:204-220.
60. Lee J.T. Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control. Nat. Rev. Mol. Cell Biol. 2011, 12:815-826.
61. Lee M.H., Yang H.Y. Regulators of G1 cyclin-dependent kinases and cancers. Cancer Metastasis Rev. 2003, 22:435-449.
62. Lee Y.B., et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell. Reprogram. 2013, 5:1178-1186.
63. Li P., et al. A Liver-Enriched Long Non-Coding RNA, lncLSTR, Regulates Systemic Lipid Metabolism in Mice. Cell Metab. 2015, 21:455-467.
64. Lippa C.F., et al. Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome. Arch. Neurol. 2009, 66:1483-1488.
65. Liu Z., et al. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat. Immunol. 2011, 12:1063-1070.
66. Liu X., et al. Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J. 2012, 31:4415-4427.
67. Lu X.H., Yang X.W. "Huntingtin holiday": progress toward an antisense therapy for Huntington's disease. Neuron 2012, 74:964-966.
68. Mackenzie I.R., et al. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010, 9:995-1007.
69. Mackenzie I.R., et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011, 122:111-113.
70. Matsui K., et al. Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes. Hepatology 2008, 47:686-697.
71. Mattick J.S., Makunin I.V. Non-coding RNA. Hum. Mol. Genet. 2006, 15:R17-R29. (Spec No 1).
72. Mesulam M.M. Primary progressive aphasia. Ann. Neurol. 2001, 49:425-432.
73. Mills J.D., et al. Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy. Neurogenetics 2015, 16:107-122.
74. Modarresi F., et al. Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis. Int. J. Alzheimers Dis. 2011, 2011:929042.
75. Mori K., et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 2013, 339:1335-1338.
76. Morris K.V., Mattick J.S. The rise of regulatory RNA. Nat. Rev. Genet. 2014, 15:423-437.
77. Muddashetty R., et al. Poly(A)-binding protein is associated with neuronal BC1 and BC200 ribonucleoprotein particles. J. Mol. Biol. 2002, 321:433-445.
78. Mus E., et al. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10679-10684.
79. Neary D., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998, 51:1546-1554.
80. Nishimoto Y., et al. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol. Brain 2013, 6:31.
81. Olive M., et al. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies. J. Neuropathol. Exp. Neurol. 2009, 68:262-273.
82. Parenti R., et al. A natural antisense transcript against Rad18, specifically expressed in neurons and upregulated during beta-amyloid-induced apoptosis. Eur. J. Neurosci. 2007, 26:2444-2457.
83. Polymenidou M., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011, 14:459-468.
84. Prasanth K.V., et al. Regulating gene expression through RNA nuclear retention. Cell 2005, 123:249-263.
85. Rademakers R., et al. Advances in understanding the molecular basis of frontotemporal dementia. Nat. Rev. Neurol. 2012, 8:423-434.
86. Rascovsky K., et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011, 134:2456-2477.
87. Renton A.E., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268.
88. Roberson E.D., et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 2005, 65:719-725.
89. Rogelj B., et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2012, 2:603.
90. Rohrer J.D., Warren J.D. Phenotypic signatures of genetic frontotemporal dementia. Curr. Opin. Neurol. 2011, 24:542-549.
91. Salajegheh M., et al. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 2009, 40:19-31.
92. Sana J., et al. Novel classes of non-coding RNAs and cancer. J. Transl. Med. 2012, 10:103.
93. Sareen D., et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med. 2013, 5. (208ra149).
94. Scheele C., et al. The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function. BMC Genomics 2007, 8:74.
95. Schwab C., et al. TDP-43 pathology in familial British dementia. Acta Neuropathol. 2009, 118:303-311.
96. Seltman R.E., Matthews B.R. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management. CNS Drugs 2012, 26:841-870.
97. Sharma S., et al. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:11381-11386.
98. Snowden J.S., et al. Frontotemporal dementia. Br. J. Psychiatry 2002, 180:140-143.
99. Soreq L., et al. Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing. PLoS Comput. Biol. 2014, 10:e1003517.
100. Stevens M., et al. Familial aggregation in frontotemporal dementia. Neurology 1998, 50:1541-1545.
101. Szafranski K., et al. Non-coding RNA in neural function, disease, and aging. Front. Genet. 2015, 6:87.
102. Thomas C., et al. Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 2008, 7:678-693.
103. Tollervey J.R., et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011, 14:452-458.
104. Tsuiji H., et al. Competition between a noncoding exon and introns: Gomafu contains tandem UACUAAC repeats and associates with splicing factor-1. Genes Cells 2011, 16:479-490.
105. Ulitsky I., Bartel D.P. lincRNAs: genomics, evolution, and mechanisms. Cell 2013, 154:26-46.
106. Wan L.B., Bartolomei M.S. Regulation of imprinting in clusters: noncoding RNAs versus insulators. Adv. Genet. 2008, 61:207-223.
107. Wang I.F., et al. Higher order arrangement of the eukaryotic nuclear bodies. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13583-13588.
108. Wang X., et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008, 454:126-130.
109. Weihl C.C., et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 2008, 79:1186-1189.
110. Wilusz J.E. Long noncoding RNAs: re-writing dogmas of RNA processing and stability. Biochim. Biophys. Acta 2015, (in press).
111. Woulfe J., et al. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol. 2010, 20:589-597.
112. Xiao S., et al. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death. Acta Neuropathol. 2015, 130:49-61.
113. Yakovchuk P., et al. B2 RNA and Alu RNA repress transcription by disrupting contacts between RNA polymerase II and promoter DNA within assembled complexes. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5569-5574.
114. Yang L., et al. Subcellular localization and RNAs determine FUS architecture in different cellular compartments 2015, Hum Mol Genet.
115. Yoon J.H., et al. LincRNA-p21 suppresses target mRNA translation. Mol. Cell 2012, 47:648-655.
116. Zhou H., et al. Non-coding RNAs and their epigenetic regulatory mechanisms. Biol. Cell. 2010, 102:645-655.